Literature DB >> 3972121

Pyridoxal phosphate-induced dissociation of the succinate: ubiquinone reductase.

Z M Choudhry, E V Gavrikova, A B Kotlyar, P R Tushurashvili, A D Vinogradov.   

Abstract

Treatment of the soluble ubiquinone-deficient succinate: ubiquinone reductase with pyridoxal phosphate results in the inhibition of the carboxin-sensitive ubiquinone-reductase activity of the enzyme. The inactivation is prevented by the soluble homolog of ubiquinone (Q2) but is insensitive to the dicarboxylates interacting with the substrate binding site of succinate dehydrogenase. The reactivity of the pyridoxal phosphate-inhibited enzyme with different electron acceptors suggests that the observed inhibition is due to the dissociation of succinate dehydrogenase from the enzyme complex. The soluble succinate dehydrogenase was recovered in the supernatant after treatment of the insoluble succinate: ubiquinone reductase with pyridoxal phosphate. The data obtained strongly suggest the participation of amino groups in the interaction between succinate dehydrogenase and the ubiquinone reactivity conferring peptide within the complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972121     DOI: 10.1016/0014-5793(85)81177-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  1 in total

1.  Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II.

Authors:  L-F Dong; P Low; J C Dyason; X-F Wang; L Prochazka; P K Witting; R Freeman; E Swettenham; K Valis; J Liu; R Zobalova; J Turanek; D R Spitz; F E Domann; I E Scheffler; S J Ralph; J Neuzil
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.